| 000 | 01390 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250517100345.0 | ||
| 264 | 0 | _c20170630 | |
| 008 | 201706s 0 0 eng d | ||
| 022 | _a1097-4598 | ||
| 024 | 7 |
_a10.1002/mus.25205 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAndersen, Jintana B | |
| 245 | 0 | 0 |
_aFactors affecting outcome in myasthenia gravis. _h[electronic resource] |
| 260 |
_bMuscle & nerve _c12 2016 |
||
| 300 |
_a1041-1049 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntibodies _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
| 650 | 0 | 4 | _aLongitudinal Studies |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMyasthenia Gravis _xblood |
| 650 | 0 | 4 |
_aReceptors, Cholinergic _ximmunology |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aStatistics, Nonparametric |
| 650 | 0 | 4 | _aThymectomy |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aGilhus, Nils Erik | |
| 700 | 1 | _aSanders, Donald B | |
| 773 | 0 |
_tMuscle & nerve _gvol. 54 _gno. 6 _gp. 1041-1049 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/mus.25205 _zAvailable from publisher's website |
| 999 |
_c26081865 _d26081865 |
||